Commonwealth v. Kaye

335 A.2d 430, 232 Pa. Super. 513, 1975 Pa. Super. LEXIS 1411
CourtSuperior Court of Pennsylvania
DecidedFebruary 27, 1975
DocketAppeal, 375
StatusPublished
Cited by5 cases

This text of 335 A.2d 430 (Commonwealth v. Kaye) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Commonwealth v. Kaye, 335 A.2d 430, 232 Pa. Super. 513, 1975 Pa. Super. LEXIS 1411 (Pa. Ct. App. 1975).

Opinion

Opinion by

Spaeth, J.,

Appellant, an osteopath, was convicted after a trial by jury of three offenses under the Drug, Device and Cosmetic Act: 1 trafficking in dangerous or narcotic drugs ; 2 prescription to a person known to be a habitual user; 3 and prescription without a physical examination. 4

On July 13, 1971, George Gariti went to appellant’s office in Coraopolis, Allegheny County, and asked appellant to issue a prescription for Numorphan. This was a very potent pain killer, usually only prescribed for use by terminal cancer patients. Appellant refused to write the prescription unless Gariti could supply the name of such a patient. Gariti called a friend, Kathy Markvan, whom he knew to have a relative whose name he could use. She gave him the name of her aunt. He wrote the name on a piece of paper, which he handed to appellant, and appellant wrote out the prescription and handed it to him. Gariti and Markvan then went to have the prescription filled in Ellwood City, where the aunt lived. *515 They got lost, however, and ended up trying to have the prescription filled at a pharmacy in Zelienople. Markvan went in to get the prescription filled while Gariti waited in the car. The pharmacist noticed that the prescription lacked the proper registration number from the Bureau of Narcotics and Dangerous Drugs. His suspicions were further aroused by the fact that the production of Nu-morphan had been halted six months before by the government, although pharmacists were permitted to sell any they still had in stock. He alerted an off-duty policeman who happened to be in the pharmacy, and Markvan and Gariti were taken into custody. The Commonwealth proved these events by the testimony of all of the persons involved (except appellant).

Albert D’Amico, a regional supervisor with the Pennsylvania Bureau of Narcotics and Drug Control, supervised the investigation of appellant. Acting on information he received from Gariti and Ron Lupinacci, he dispatched Agents Burke and Roy to various pharmacies in the general area of Ambridge, Beaver County, to inspect and search for prescriptions written by appellant and issued to Gariti and Lupinacci, in both their actual names and their several aliases. This investigation yielded at least thirty-seven illegal prescriptions written over a period of about sixteen months: two for Numorphan (the second having been issued in the name of a dead man), twenty-six for Desoxyn, three for Nembutal, four for Desbutal, one for Dilaudid, and one for Quaalude. 5 D’Amico, Burke, and Roy testified as to the manner in which the investigation and inspection were conducted, *516 and they identified the prescriptions and the pharmacies from which they were seized. In addition, the pharmacists who filled or supervised the filling of the various prescriptions identified the prescriptions; and some of the pharmacists also testified as to the manner in which the inspection was conducted.

Gariti, Lupinacci, and Dennis Maher had all bought prescriptions for various drugs, principally Desoxyn, from appellant at his office in Ambridge. Lupinacci and Maher testified about a time span beginning in 1968; Gariti testified that he bought prescriptions continuously from February, 1971. Each said he paid $5.00 or $6.00 for each prescription, and that appellant never gave a physical examination in connection with any of the prescriptions. Lupinacci testified that during one period he was buying as many as six or seven prescriptions a week; Gariti testified that sometimes he would buy as many as three or four a week. In addition, Gariti testified that appellant sold him prescriptions for morphine on a regular basis, although no such prescriptions were introduced in evidence.

Several secretary-assistants who worked for appellant during the period in question testified that Gariti and Lupinacci often came to see appellant, and that appellant handed them folded pieces of paper that appeared to come from his prescription pad. They also said it was their duty to keep certain records on every patient and prescription and to aid appellant when he conducted a physical examination, but that none of these procedures was followed here.

As part of his defense, appellant took the stand and denied ever issuing any illegal prescription to Gariti or Lupinacci. He also presented witnesses whose testimony was intended to impeach the credibility of the Commonwealth’s witnesses. Testimony was also presented that his offices had been burglarized and that prescription pads could have been stolen.

*517 Appellant has raised several issues on this appeal, but the only ones that will be considered are the three that were raised in the court below. 6

Appellant contends that a new trial should be granted because, in his words, “there is gross conflict between material witnesses as to essential facts upon which [appellant’s] guilt is based, indicating the strong possibility of perjury .. ,” 7 This contention is based on the fact that if Gariti and Lupinacci are to be believed, they must have received many more prescriptions than the thirty eight 8 introduced at the trial. Since Agent Burke testified that *518 all of the prescriptions that the investigation turned up were introduced at trial, the argument goes, somebody must have been lying, and a new trial should be granted.

Appellant cites no cases where perjury was found obvious on the face of the record, and independent research has revealed none. However, even when a witness has recanted testimony under oath, an appellate court will not interfere with an order refusing a new trial unless there has been a plain abuse of discretion. Commonwealth v. Mosteller, 446 Pa. 83, 284 A.2d 786 (1971) ; Commonwealth v. Coleman, 438 Pa. 373, 264 A.2d 649 (1970) ; Commonwealth v. Fernandez, 232 Pa. Superior Ct. 19, 332 A.2d 819 (1974) ; Commonwealth v. Osborn, 223 Pa. Superior Ct. 523, 302 A.2d 395 (1973) ; Commonwealth v. Sholder, 201 Pa. Superior Ct. 642, 193 A.2d 632 (1963). If a reversal is not automatic after a sworn recantation, it is certainly not so when there is only a possibility of perjury, for that possibility always exists. In any case, the premise of appellant’s argument fails, for there is not the inconsistency in the testimony he says there is.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Com. v. Henderson, S.
Superior Court of Pennsylvania, 2022
Com. v. Martinez-Diaz, C.
Superior Court of Pennsylvania, 2022
Commonwealth v. Fawcett
443 A.2d 1172 (Superior Court of Pennsylvania, 1982)
Commonwealth v. Strickler
393 A.2d 313 (Supreme Court of Pennsylvania, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
335 A.2d 430, 232 Pa. Super. 513, 1975 Pa. Super. LEXIS 1411, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commonwealth-v-kaye-pasuperct-1975.